Results 101 to 110 of about 147,441 (251)

Geographical Disparities in the Distribution of Community Pharmacies Providing Aseptic Preparation Services in Japan

Integrated Pharmacy Research and Practice
Kazuya Nonomura,1,2 Kazuya Toyama,1 Yufu Kondo,1 Hirofumi Tamaki,1 Arihiro Osanai,1 Yoko Ino,3 Mitsuhiro Nakamura,4 Kazuhiro Iguchi1 1Laboratory of Community Pharmacy, Gifu Pharmaceutical University, Gifu, Japan; 2Mamiya Dispensing Pharmacy, Gifu, Japan;
Nonomura K, Toyama K, Kondo Y, Tamaki H, Osanai A, Ino Y, Nakamura M, Iguchi K   +7 more
doaj  

Research Status and Prospect of Cross-regional Medical Treatment in China Based on Bibliometric Analysis [PDF]

Zhongguo quanke yixue
Background In the context of fragmented medical insurance and normalized population mobility, how to provide more convenient and efficient medical fee settlement services for patients with cross-regional medical treatment has become a hot issue of common
LIU Chang, WANG Yufei
doaj   +1 more source

Health Care Opinion Leaders' Views on Payment System Reform [PDF]

, 2008
Presents results of a survey of healthcare experts on the adequacy of the current fee-for-service payment system, reform options, strategies to improve efficiency and effectiveness, and changes to Medicare.
Karen Davis, Kristof Stremikis, Stuart Guterman   +2 more
core  

Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan

Clinical Pharmacology &Therapeutics, EarlyView.
With the increasing volume of clinical evidence derived from large‐scale Asian real‐world data (RWD) and the growing interest in its use in regulatory decision‐making, it is important to conduct benchmarking exercises that evaluate whether studies using Asian RWD can generate similar conclusions as randomized controlled trials (RCTs).
Hwa Yeon Ko, Philip C. M. Au, Michael Chun‐Yuan Cheng, Ching‐Lung Cheung, Ahhyung Choi, Miyuki Hsing‐Chun Hsieh, Han Eol Jeong, Edward Chia‐Cheng Lai, Brian Meng‐Hsun Li, Kenneth K. C. Man, Jeremy A. Rassen, Daniel Hsiang‐Te Tsai, Shirley V. Wang, Ian C. K. Wong, Ju‐Young Shin, Sohee Park   +15 more
wiley   +1 more source

Measuring the Impact of the Substitution of Innovator Biologics With Biosimilars on Uptake and Costs Among Ontario Public Drug Benefit Recipients

Clinical Pharmacology &Therapeutics, EarlyView.
In Ontario, biologics have historically represented a small proportion of public drug claims but a large proportion of spending. Biosimilars, lower cost alternatives to biologics, offer a potential solution to the rising spending on biologics. From March 2023 to January 2024, the Ontario Ministry of Health required public drug program beneficiaries on ...
Anita Iacono, Martin K. H. Ho, Joanna Yang, Tonya Campbell, William Wynne, Dana Shearer, Lene Andersen, Eric Majer, Shaleesa Ledlie, Mina Tadrous, Tara Gomes   +10 more
wiley   +1 more source

Patient Satisfaction Level of Chronic Illness National Health Insurance to Pharmaceutical Services

, 2023
Kamelia Agustini, Ratih Hurriyati, Bambang Widjajanta, Akhmad Priyadi, Ratna Puspitasari   +4 more
openaire   +1 more source

Public Private Partnership for Equitable Provision of Quality Health Services [PDF]

, 2005
This report presents the findings of an independent Technical Review that focused on the promotion of Public Private Partnership (PPP) for equitable provision of quality health services in Tanzania.
Health Research for Action, (HERA)
core  

Association of Neurodevelopmental Disorders and Congenital Anomalies With Prenatal Multiple Sclerosis Treatment—Real‐World Historical Cohort Study

Clinical Pharmacology &Therapeutics, EarlyView.
There is a paucity of data regarding the effects of prenatal disease‐modifying therapies (DMTs) for multiple sclerosis (MS), on congenital anomalies in the offspring. Moreover, data on the association with neurodevelopmental disorders are lacking. This is an historical cohort study, within the Israeli Clalit Health Services database (2005–2024) that ...
Bar Rosh, Ofek Levi, Nili Stein, Amir Yahav, Naomi Gronich   +4 more
wiley   +1 more source

A comparison of the direct medical costs for individuals with or without basal or squamous cell skin cancer: A study from Australia

SAGE Open Medicine, 2016
Objectives: The composition of the medical costs incurred by people treated for basal cell and squamous cell carcinomas (hereafter keratinocyte cancers) is not adequately understood.
David Rowell, Louisa G Gordon, Catherine M Olsen, David C Whiteman   +3 more
doaj   +1 more source

Patient‐ and Clinician‐Related Factors Associated With the Reduction in Opioid Use Among Adults With Chronic Non‐Cancer Pain: A Systematic Review

Clinical Pharmacology &Therapeutics, EarlyView.
Despite known risks, opioids are widely used for chronic non‐cancer pain (CNCP). Clinical guidelines now recommend deprescribing, but factors predicting success are poorly understood. This systematic review aimed to identify clinician and patient factors associated with attaining successful opioid dose reduction or discontinuation in adults with CNCP ...
Alessandra C. Marcelo, Sarah N. Hilmer, David J. Hunter, Stephanie Mathieson, Riyaas Mohamed, Leo Li, Natalie Fung, Anthony Yue, Manuela L. Ferreira   +8 more
wiley   +1 more source